View Memorandum
Cannarise Cultivation Group (CCG)
South Australia
Reasons to invest in the project:
-
Strategic Land Acquisition: The Company owns a 250-acre rural property that is strategically located with ample access to natural resources, including water, essential for the cultivation of cannabis.
-
Regulatory Approvals: The Company has secured local council approvals and a cultivation license from the ODC, providing a strong foundation for operations.
-
Strong Industry Expertise: The board includes influential figures from both Australian and International cannabis markets, with significant experience in cultivation and regulatory compliance.
-
Market Growth: The medicinal cannabis market in Australia is expanding rapidly, and CCG is poised to capitalize on this emerging opportunity.
-
Minimal Environmental Impact: The land is situated in a rural area surrounded by farmland, minimising any impact on surrounding properties and the local environment.
-
Opportunity: Investors can purchase Redeemable Preferential Units with a 20% Coupon Rate, offering an attractive return on investment over the first three years of operation.
Financial terms of the investment :
Investment
$6,000,000 with minimum investment of $200,000
6 Million Redeemable Preference Units (RPU)
1st charge Mortgage
20% Coupon Rate Per Annum
Redeemable 3 Years
Project Description:
Cannarise Cultivation Group: Pioneering Medicinal Cannabis in Australia is setting New Standards in Cultivation and Production.
Cannarise Cultivation Group (CCG) is an Australian-based medicinal cannabis company that has recently achieved a significant milestone in its journey. The company has been granted a Class 1 Medicinal Cultivation conditional license by the Office of Drug Control (ODC) in Australia. This achievement marks the beginning of CCG's ambitious plan to cultivate and produce premium cannabis products tailored for the Australian market, with the potential for future expansion into international territories.
Strategic Vision and Location
CCG's cultivation operations are strategically situated on a 250-acre rural plot in South Australia. This location offers the optimal conditions for cannabis cultivation, combining favorable climate and soil quality to ensure the highest standards of product quality. In addition, the company is in the planning stages of constructing a purpose-built 11,250 square meter facility designed to support its extensive cultivation and production activities.
The Growth of the Australian Medicinal Cannabis Market
The Australian medicinal cannabis market is on the cusp of significant growth in the coming years. Several key factors contribute to this expansion, creating a fertile ground for companies like CCG to thrive.
Demographic Shifts and Patient Demand
One of the primary drivers of growth is the aging population in Australia. As the population ages, there is an increased demand for alternative treatments to manage chronic conditions and improve quality of life. Medicinal cannabis has emerged as a promising alternative, offering therapeutic benefits for a range of ailments.
Scientific Advancements and Public Awareness
The growing body of scientific evidence supporting the medical benefits of cannabis has played a critical role in shaping public perception and acceptance. Increased public awareness of the therapeutic potential of cannabis has led to a surge in demand for medicinal cannabis products. This shift in public opinion is further bolstered by the growing acceptance of medical marijuana by healthcare professionals and policymakers.
Market Projections
According to a report by Grand View Research, the Australian legal cannabis market was valued at USD 51.8 million in 2021. The market is expected to expand at a compound annual growth rate (CAGR) of 30.1% from 2022 to 2030. This remarkable growth trajectory underscores the significant opportunities for companies like CCG to capture market share and establish themselves as leaders in the industry.
Investment Opportunities with CCG
To support its growth ambitions, CCG is set on raising $6,000,000 through the issuance of 6 Million Redeemable Preference Units (RPU). These units offer a 20% coupon rate per annum and are redeemable within three years. This investment opportunity presents a compelling proposition for investors seeking exposure to the burgeoning medicinal cannabis market in Australia.
Private Clients Manager
Phone: 1800 858 696
Frequently asked questions
We've updated the chatbot on this page with all the answers, ask something like "What year did the business start? .
Key investment risks :
When considering purchasing or investing in a business, it's important to be aware of the potential risks involved. It is advisable to consult with your accounting and legal advisors before entering into any contracts. While we strive to exercise due diligence, we cannot guarantee the accuracy of the project. It is essential that you verify all financials and legal agreements before proceeding.
